Tehran University of Medical Sciences

Science Communicator Platform

Share By
Gold Cluster Encapsulated Liposomes: Theranostic Agent With Stimulus Triggered Release Capability Publisher Pubmed



Amini SM1, 2 ; Rezayat SM2, 3 ; Dinarvand R4 ; Kharrazi S2 ; Jaafari MR5, 6
Authors

Source: Medical Oncology Published:2023


Abstract

Cancer is a major cause of death worldwide. Cancer-resistant to chemo or radiotherapy treatment is a challenge that could be overcome by a nanotechnology approach. Providing a theranostic nano-platform for different cancer treatment strategies could be revolutionary. Here we introduce a multifunctional theranostic nanostructure which has the capacity for improving cancer diagnosis and treatment through better chemo and radiotherapy and current x-ray imaging systems through co-encapsulation of a small gold cluster and anticancer drug doxorubicin. 2 nm gold clusters represent good heating under radio frequency electric field (RF-EF) exposure and have been used for in vitro hyperthermia treatment of cancerous cells. Liposomal doxorubicin (169 ± 19.8 nm) with gold clusters encapsulation efficiency of 13.2 ± 3.0% and doxorubicin encapsulation efficiency of 64.7 ± 0.7% were prepared and studied as a theranostic agent with a high potential in different cancer treatment modalities. Exposure to a radiofrequency electric field on prepared formulation caused 20.2 ± 2.1% drug release and twice decreasing of IC50 on colorectal carcinoma cells. X-ray attenuation efficiency of the liposomal gold cluster was better than commercial iohexol and free gold clusters in different concentrations. Finally, treatment of gold clusters on cancerous cells results in a significant decrease in the viability of irradiated cells to cobalt-60 beam. Based on these experiments, we concluded that the conventional liposomal formulation of doxorubicin that has been co-encapsulated with small gold clusters could be a suitable theranostic nanostructure for cancer treatment and merits further investigation. © 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
3. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
Experts (# of related papers)
Other Related Docs
6. Folate-Conjugated Gold Nanoparticle As a New Nanoplatform for Targeted Cancer Therapy, Journal of Cancer Research and Clinical Oncology (2016)
8. Metallic Nanoparticles for the Modulation of Tumor Microenvironment; a New Horizon, Frontiers in Bioengineering and Biotechnology (2022)
10. Gold Nanoparticles for Biomedical Imaging and Their Biological Response, New Developments in Gold Nanomaterials Research (2016)
13. The Use of Nanoparticles As a Promising Therapeutic Approach in Cancer Immunotherapy, Artificial Cells# Nanomedicine and Biotechnology (2016)
17. Nanovehicles for Co-Delivery of Anticancer Agents, Drug Discovery Today (2020)